Menu

Condition

Psychedelics for ADHD: what the evidence shows

Long-standing problems with attention, restlessness and impulsivity, here in adults.

Last reviewed 23 October 2026Re-checked every month2 substances with published evidence

Where are these treatments legal?See country-by-country rules on our Psychedelic Therapy Legality Map

Substance by substance

One card per substance, strongest evidence first. A substance that isn’t here has no published clinical evidence for this condition yet.

LSD

Little or no evidence

Properly tested — and microdosing didn't work.

In a placebo-controlled trial of 53 adults, LSD microdoses twice a week for six weeks did no better than placebo. Both groups improved, and those who believed they got LSD improved more.2

Keep reading

Sources

Numbered in the order they appear above. We only use peer-reviewed papers, official company announcements (for trial status and topline results), regulators and trial registries.

  1. Cooper RE et al. Cannabinoids in attention-deficit/hyperactivity disorder: a randomised-controlled trial. Eur Neuropsychopharmacol. 2017Journal
  2. Mueller L et al. Safety and efficacy of repeated low-dose LSD for ADHD treatment in adults: a randomized clinical trial. JAMA Psychiatry. 2025Journal